Y
Yan-fen Wang
Researcher at Nanjing University
Publications - 5
Citations - 129
Yan-fen Wang is an academic researcher from Nanjing University. The author has contributed to research in topics: PAX8 & SWI/SNF. The author has an hindex of 5, co-authored 5 publications receiving 104 citations.
Papers
More filters
Journal Article
Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
Cai-Xia Wang,Biao Liu,Yan-fen Wang,Ru-song Zhang,Bo Yu,Zhen-feng Lu,Qun-Li Shi,Xiao-jun Zhou +7 more
TL;DR: 9 cases of PEAC are reported and a panel of immunohistochemical protein markers of CK7, CK20, thyroid transcription factor 1 (TTF-1), Napsin A, MUC2 and villin was analyzed, confirming that PEAC has a separate phenotype from usual pulmonary adenocarcinoma.
Journal Article
Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features
Qiu-Yuan Xia,Qiu Rao,Qin Shen,Shanshan Shi,Li Li,Biao Liu,Jin Zhang,Yan-fen Wang,Qun-Li Shi,Jiandong Wang,Heng-hui Ma,Zhen-feng Lu,Bo Yu,Ru-song Zhang,Xiao-jun Zhou +14 more
TL;DR: The results suggest that OPRCC shows distinct morphology, indolent clinical behavior, and similar immunohistochemical and cytogenetic features with PRCC, seems to be a variant in the PRCC group.
Journal ArticleDOI
Thyroid carcinoma showing thymus-like elements: a clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis.
Yan-fen Wang,Biao Liu,Xiangshan Fan,Qiu Rao,Yan Xu,Qiu-Yuan Xia,Bo Yu,Shanshan Shi,Xiao-jun Zhou +8 more
TL;DR: GLut-1 can be used as a novel biomarker for CASTLE, and combined detection of GLUT-1 with CD5 and CD117 aids in the diagnosis of this tumor.
Journal ArticleDOI
Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
Qiu Rao,Qiu-Yuan Xia,Zi-yu Wang,Li Li,Qin Shen,Shanshan Shi,Xuan Wang,Biao Liu,Yan-fen Wang,Qun-Li Shi,Heng-hui Ma,Zhen-feng Lu,Yan He,Ru-song Zhang,Bo Yu,Xiao-jun Zhou +15 more
TL;DR: The aim of this study was to explore the status of multiple key subunits of the SWI/SNF complex in MRTs, and to investigate the role of SMARCB1 in this complex.
Journal ArticleDOI
Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma.
Qiu yuan Xia,Qiu Rao,Liang Cheng,Qin Shen,Shan shan Shi,Li Li,Biao Liu,Jin Zhang,Yan-fen Wang,Qun li Shi,Jian dong Wang,Heng hui Ma,Zhen feng Lu,Bo Yu,Ru song Zhang,Xiao Jun Zhou +15 more
TL;DR: The aim of this study was to examine the status of Brahma (BRM), a key SWI/SNF complex subunit, in clear cell renal cell carcinomas (RCCs), and to analyse the histopathology, immunophenotype, molecular features and prognosis of the BRM‐negative cases.